https://orcid.org/0000-0002-0070-9197
References
- Horie T, Kimura T, Ono K. Emerging novel biomarkers for arteriosclerosis obliterans. J Atheroscler Thromb. 2016; 232:171–172. doi:10.5551/jat.ED028.
- Malgor RD, Alahdab F, Elraiyah TA, et al. A systematic review of treatment of intermittent claudication in the lower extremities. J Vasc Surg. 2015;61(3):54S–73S. doi:10.1016/j.jvs.2014.12.007.
- Reinecke H, Unrath M, Freisinger E, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J. 2015;3615:932–938. doi:10.1093/eurheartj/ehv006.
- Marasciulo FL, Montagnani M, Potenza MA. Endothelin-1: the yin and yang on vascular function. CMC. 2006;13(14):1655–1665. doi:10.2174/092986706777441968.
- Daka B, Olausson J, Larsson CA, et al. Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skövde Cohort. BMC Cardiovasc Disord. 2015;15(1):146. doi:10.1186/s12872-015-0141-y.
- Freixa X, Heras M, Ortiz JT, et al. Usefulness of endothelin-1 assessment in acute myocardial infarction. Rev Esp Cardiol. 2011;64(2):105–110. doi:10.1016/j.rec.2010.06.001.
- Karabağ Y, Çağdaş M, Rencuzogullari I, et al. Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. J Clin Lab Anal. 2018;32(7):e22457. doi:10.1002/jcla.22457.
- Çınar T, Çağdaş M, Rencüzoğulları İ, et al. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction. Scand Cardiovasc J. 2019;53(2):83–90. doi:10.1080/14017431.2019.1590628.
- Bleda S, De Haro J, Acin F, et al. Inflammatory burden predicts long-term outcomes in endovascular therapy in peripheral arterial disease. Ann Vasc Surg. 2013;27(4):459–466. doi:10.1016/j.avsg.2012.02.027.
- Lian W, Nie H, Jin J, et al. Clinical significance of endothelin-1 and C reaction protein in restenosis after the intervention of lower extremity arteriosclerosis obliterans. J Invest Surg. 2021;34(7):765–770. doi:10.1080/08941939.2019.1690600.